ELIGIBILITY FOR
TIL THERAPY
More patients may qualify for TIL therapy than they expect. Here is how eligibility is actually assessed โ in plain terms.
There Is No Single Test That Decides This
Eligibility for TIL therapy is a picture built from multiple factors looked at together โ cancer type, treatment history, tumor accessibility, organ function, and daily functioning. None of these factors work in isolation.
โBeing heavily pre-treated is frequently what makes someone the right candidate, not the wrong one.โ
Factors That Support vs Complicate Eligibility
Understanding both sides helps patients have more grounded conversations with specialists.
Factors That Support Eligibility
- Confirmed solid tumorMelanoma, cervical, lung, head and neck โ most studied indications.
- Prior treatment failureMost programs enroll patients who progressed through 1-2 prior lines.
- Measurable disease on imagingActive, measurable tumor visible on recent scans.
- Adequate organ functionKidney, liver, and cardiac function within acceptable ranges.
Factors That Complicate (Not Disqualify)
- Significant functional declineMay need stabilization before treatment is feasible.
- Difficult-to-biopsy tumorsSome locations create challenges โ but alternative access approaches exist.
- Active autoimmune diseaseRequiring immunosuppressive medications may complicate eligibility.
- Recent major surgery or active infectionTypically requires resolution before starting the TIL process.
What Most Programs Are Looking For
Most TIL therapy programs are looking for patients with these general characteristics:
Confirmed solid tumor diagnosis
With measurable disease on recent imaging scans.
Adequate organ function
Kidney, liver, and cardiac function evaluated and within range.
No severe uncontrolled autoimmune conditions
Active autoimmune disease requiring immunosuppression may be a barrier.
No active serious infection
Infections need to be resolved before the conditioning phase begins.
Ability to commit proximity to treatment center
Patients must remain near the center during active treatment phases.
Signs It Is Time to Explore TIL Therapy
- 1
Standard Options Have Run Out
Treatment options from your oncologist have been exhausted or are no longer working.
- 2
Clinical Trials Are Being Raised
Your oncologist is mentioning clinical trials as a path forward โ standard options are limited.
- 3
Seeking a Full Global Picture
You want to understand everything available globally, not just locally.
Frequently Asked Questions
TIL Therapy Eligibility
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Want to Know If You Qualify for TIL Therapy?
Upload your medical reports for a specialist eligibility review. Initial assessment is based on your cancer type, treatment history, and current imaging.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.